Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - NetShares Repurchased
Ratios

Prestige Consumer Healthcare (PBH) EBIAT (2016 - 2025)

Prestige Consumer Healthcare has reported EBIAT over the past 16 years, most recently at $46.7 million for Q4 2025.

  • Quarterly results put EBIAT at $46.7 million for Q4 2025, down 23.49% from a year ago — trailing twelve months through Dec 2025 was $186.5 million (down 12.82% YoY), and the annual figure for FY2025 was $214.6 million, up 2.52%.
  • EBIAT for Q4 2025 was $46.7 million at Prestige Consumer Healthcare, up from $42.2 million in the prior quarter.
  • Over the last five years, EBIAT for PBH hit a ceiling of $61.0 million in Q4 2024 and a floor of -$240.6 million in Q1 2023.
  • Median EBIAT over the past 5 years was $50.6 million (2021), compared with a mean of $35.9 million.
  • Biggest five-year swings in EBIAT: tumbled 561.84% in 2023 and later surged 120.56% in 2024.
  • Prestige Consumer Healthcare's EBIAT stood at $50.2 million in 2021, then rose by 3.46% to $52.0 million in 2022, then increased by 2.11% to $53.0 million in 2023, then increased by 15.05% to $61.0 million in 2024, then decreased by 23.49% to $46.7 million in 2025.
  • The last three reported values for EBIAT were $46.7 million (Q4 2025), $42.2 million (Q3 2025), and $47.5 million (Q2 2025) per Business Quant data.